Latest Intelligence in Japan

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

Young drivers: design matters

A raft of recent vehicle launches, in particular from Japanese manufacturers, has demonstrated the automotive industry's obsession with the so-called Generation-Y market. But designing specific lifestyle oriented vehicles is a gamble that may not pay off.

Published By Datamonitor
16 Jan 2003
CommentWire
CommentWire

Yamanouchi/Fujisawa: still some way from world domination

The relatively small size of Japanese pharma players means that independent overseas growth can only take them so far, with international subsidiaries lacking the scale to promote a blockbuster drug. The tie up of Yamanouchi and Fujisawa represents the first step towards a global mega-player, but further partnerships will be essential to enter the top tier of global pharma companies.

Published By Datamonitor
25 Feb 2004
CommentWire
CommentWire

Yamanouchi / Fujisawa: a stellar future

Yamanouchi [4503.TO] and Fujisawa [4511.TO] have revealed that their post-merger company will be known as Astellas. The combined company is expected to become Japan's largest pharmaceutical company, with cardiovascular and AIID products expected to drive growth in the medium term. Although Astellas will face stiff competition, it should prove a good move for both firms.

Published By Datamonitor
26 May 2004
Expert View
Expert View

Xigris: Lilly's sepsis flop misses out

Eli Lilly's Xigris sales have proved disappointing, for the year-to-date period ending February 28 2002 sales reached just $14 million, bringing total sales to $35 million since the drug's launch in late November 2001. Industry analysts had predicted sales of between $300 and $500 million in 2002, but this now seems unrealistic, so where did it all go wrong?

Published By Datamonitor
22 Mar 2002
ResearchWire
ResearchWire

Women's health: 7.2 million PCOS sufferers in the US

Published By Datamonitor
08 May 2002
ResearchWire
ResearchWire

Women's health: 20 million HPV sufferers in the US

Published By Datamonitor
15 May 2002
CommentWire
CommentWire

wLANs: taking the trophy

Avaya's wLAN linked World Cup stadiums, officials, volunteers, local authorities and the media in a major feat of networking. Meanwhile, BT has announced widespread wLAN roll-out plans in the UK. These stories highlight that wLAN technology is increasingly viable; converged LAN networking is the next major step in telecoms.

Published By Datamonitor
08 Jul 2002
Expert View
Expert View

Western invasion threatens Japanese pharma's survival

After the US, the Japanese market is the second largest pharmaceutical market in the world, with estimated sales of $54 billion in 2003. While the size of the Japanese market makes it an attractive target for western companies' expansion plans, domestic players are finding it increasingly difficult to survive.

Published By Datamonitor
12 Apr 2005
CommentWire
CommentWire

Welfide/Mitsubishi-Tokyo: uniting against the gaijin

Published By Datamonitor
03 Nov 2000
ResearchWire
ResearchWire

Wealth management: Japan has the most rising stars

Published By Datamonitor
03 May 2002

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.